FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
1970-01-01 08:00
How a national blood shortage could impact people with sickle cell disease
Dima Hendricks said as a Black woman with a chronic illness she never thought she would be able to fulfill her dream of competing in national beauty pageants.
1970-01-01 08:00
Kenya sickle cell: Fighting to dispel the myths around the disease
Kenyan Lea Kilenga Bey campaigns for better treatment for those who have the genetic disease.
1970-01-01 08:00